Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
- PMID: 20198645
- DOI: 10.1002/mds.23012
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease
Abstract
We previously reported the occurrence of Lewy bodies in grafted human fetal mesencephalic neurons in two patients with Parkinson's disease. Here, we have used immunohistochemistry and electron microscopy to characterize the development of Lewy bodies in one of these cases. This patient was operated in putamen on both sides at 12 or 16 years before death, respectively. We demonstrate that 2% of the 12-year-old and 5% of the 16-year-old grafted, presumed dopaminergic neurons contained Lewy bodies immunoreactive for alpha-synuclein. Based on morphological analysis, two forms of alpha-synuclein-positive aggregates were distinguished in the grafts, the first a classical and compact Lewy body, the other a loose meshwork aggregate. Lewy bodies in the grafts stained positively for ubiquitin and thioflavin-S, and contained characteristic alpha-synuclein immunoreactive electron dense fibrillar structures on electron microscopy. Our data indicate that Lewy bodies develop gradually in transplanted dopaminergic neurons in a fashion similar to that in dopaminergic neurons in the host substantia nigra.
(c) 2010 Movement Disorder Society.
Similar articles
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.Acta Neuropathol. 2007 Sep;114(3):231-41. doi: 10.1007/s00401-007-0244-3. Epub 2007 Jun 19. Acta Neuropathol. 2007. PMID: 17576580
-
Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.Eur J Neurosci. 2005 Jan;21(2):317-26. doi: 10.1111/j.1460-9568.2005.03870.x. Eur J Neurosci. 2005. PMID: 15673432
-
Lewy body pathology in fetal grafts.Ann N Y Acad Sci. 2010 Jan;1184:55-67. doi: 10.1111/j.1749-6632.2009.05229.x. Ann N Y Acad Sci. 2010. PMID: 20146690 Review.
-
Research in motion: the enigma of Parkinson's disease pathology spread.Nat Rev Neurosci. 2008 Oct;9(10):741-5. doi: 10.1038/nrn2477. Epub 2008 Sep 4. Nat Rev Neurosci. 2008. PMID: 18769444 Review.
Cited by
-
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.Int J Mol Sci. 2016 Jun 8;17(6):904. doi: 10.3390/ijms17060904. Int J Mol Sci. 2016. PMID: 27338353 Free PMC article. Review.
-
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons.Front Cell Dev Biol. 2020 Sep 4;8:559791. doi: 10.3389/fcell.2020.559791. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015057 Free PMC article. Review.
-
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein.Acta Neuropathol Commun. 2013 Jul 17;1:38. doi: 10.1186/2051-5960-1-38. Acta Neuropathol Commun. 2013. PMID: 24252149 Free PMC article.
-
Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report.Parkinsonism Relat Disord. 2020 Feb;71:36-39. doi: 10.1016/j.parkreldis.2019.12.013. Epub 2020 Jan 11. Parkinsonism Relat Disord. 2020. PMID: 32004818 Free PMC article.
-
Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Prog Neurobiol. 2018 Sep;168:1-20. doi: 10.1016/j.pneurobio.2018.04.005. Epub 2018 Apr 11. Prog Neurobiol. 2018. PMID: 29653250 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical